Thus, YAPon and YAPoff cancers exhibit dramatically different chromatin landscapes, and many silenced genomic loci in YAPoff cancers map to YAP/TEAD/AP1 binding sites, supporting the notion that distinct chromatin landscapes may influence differing YAP/TEAD activity. The gene discussed is YAP1; the disease is cancer.